These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 20205984)

  • 1. Results of a randomized phase I dose-finding trial of several doses of isoflavones in men with localized prostate cancer: administration prior to radical prostatectomy.
    Kumar NB; Kang L; Pow-Sang J; Xu P; Allen K; Riccardi D; Besterman-Dahan K; Krischer JP
    J Soc Integr Oncol; 2010; 8(1):3-13. PubMed ID: 20205984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Phase II randomized, placebo-controlled clinical trial of purified isoflavones in modulating steroid hormones in men diagnosed with localized prostate cancer.
    Kumar NB; Krischer JP; Allen K; Riccardi D; Besterman-Dahan K; Salup R; Kang L; Xu P; Pow-Sang J
    Nutr Cancer; 2007; 59(2):163-8. PubMed ID: 18001210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of a Randomized Clinical Trial of the Action of Several Doses of Lycopene in Localized Prostate Cancer: Administration Prior to Radical Prostatectomy.
    Kumar NB; Besterman-Dahan K; Kang L; Pow-Sang J; Xu P; Allen K; Riccardi D; Krischer JP
    Clin Med Urol; 2008 Apr; 1():1-14. PubMed ID: 20354574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term soy isoflavone intervention in patients with localized prostate cancer: a randomized, double-blind, placebo-controlled trial.
    Hamilton-Reeves JM; Banerjee S; Banerjee SK; Holzbeierlein JM; Thrasher JB; Kambhampati S; Keighley J; Van Veldhuizen P
    PLoS One; 2013; 8(7):e68331. PubMed ID: 23874588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase II randomized clinical trial using aglycone isoflavones to treat patients with localized prostate cancer in the pre-surgical period prior to radical prostatectomy.
    Kumar NB; Pow-Sang J; Spiess P; Dickinson S; Schell MJ
    Oncotarget; 2020 Apr; 11(14):1218-1234. PubMed ID: 32292572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of apoptosis in low to moderate-grade human prostate carcinoma by red clover-derived dietary isoflavones.
    Jarred RA; Keikha M; Dowling C; McPherson SJ; Clare AM; Husband AJ; Pedersen JS; Frydenberg M; Risbridger GP
    Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1689-96. PubMed ID: 12496063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lycopene and soy isoflavones in the treatment of prostate cancer.
    Vaishampayan U; Hussain M; Banerjee M; Seren S; Sarkar FH; Fontana J; Forman JD; Cher ML; Powell I; Pontes JE; Kucuk O
    Nutr Cancer; 2007; 59(1):1-7. PubMed ID: 17927495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a diet rich in phytoestrogens on prostate-specific antigen and sex hormones in men diagnosed with prostate cancer.
    Dalais FS; Meliala A; Wattanapenpaiboon N; Frydenberg M; Suter DA; Thomson WK; Wahlqvist ML
    Urology; 2004 Sep; 64(3):510-5. PubMed ID: 15351581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of purified isoflavones in men with clinically localized prostate cancer.
    Kumar NB; Krischer JP; Allen K; Riccardi D; Besterman-Dahan K; Salup R; Kang L; Xu P; Pow-Sang J
    Nutr Cancer; 2007; 59(2):169-75. PubMed ID: 18001211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The specific role of isoflavones in reducing prostate cancer risk.
    Kumar NB; Cantor A; Allen K; Riccardi D; Besterman-Dahan K; Seigne J; Helal M; Salup R; Pow-Sang J
    Prostate; 2004 May; 59(2):141-7. PubMed ID: 15042614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics and pharmacokinetics of purified soy isoflavones: multiple-dose administration to men with prostate neoplasia.
    Fischer L; Mahoney C; Jeffcoat AR; Koch MA; Thomas BE; Valentine JL; Stinchcombe T; Boan J; Crowell JA; Zeisel SH
    Nutr Cancer; 2004; 48(2):160-70. PubMed ID: 15231450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of radical prostatectomy on serum hormone levels.
    Miller LR; Partin AW; Chan DW; Bruzek DJ; Dobs AS; Epstein JI; Walsh PC
    J Urol; 1998 Aug; 160(2):449-53. PubMed ID: 9679896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined inhibitory effects of soy isoflavones and curcumin on the production of prostate-specific antigen.
    Ide H; Tokiwa S; Sakamaki K; Nishio K; Isotani S; Muto S; Hama T; Masuda H; Horie S
    Prostate; 2010 Jul; 70(10):1127-33. PubMed ID: 20503397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soy isoflavones in the treatment of prostate cancer.
    Hussain M; Banerjee M; Sarkar FH; Djuric Z; Pollak MN; Doerge D; Fontana J; Chinni S; Davis J; Forman J; Wood DP; Kucuk O
    Nutr Cancer; 2003; 47(2):111-7. PubMed ID: 15087261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate cancer chemoprevention study: an investigative randomized control study using purified isoflavones in men with rising prostate-specific antigen.
    Miyanaga N; Akaza H; Hinotsu S; Fujioka T; Naito S; Namiki M; Takahashi S; Hirao Y; Horie S; Tsukamoto T; Mori M; Tsuji H
    Cancer Sci; 2012 Jan; 103(1):125-30. PubMed ID: 21988617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Prostate cancer Intervention Versus Observation Trial:VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): design and baseline results of a randomized controlled trial comparing radical prostatectomy to watchful waiting for men with clinically localized prostate cancer.
    Wilt TJ; Brawer MK; Barry MJ; Jones KM; Kwon Y; Gingrich JR; Aronson WJ; Nsouli I; Iyer P; Cartagena R; Snider G; Roehrborn C; Fox S
    Contemp Clin Trials; 2009 Jan; 30(1):81-7. PubMed ID: 18783735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized, Placebo-Controlled Six-Month Intervention Study of Soy Protein Isolate in Men with Biochemical Recurrence after Radical Prostatectomy: A Pilot Study.
    Bosland MC; Schmoll J; Watanabe H; Randolph C; Kato I
    Nutr Cancer; 2022; 74(2):555-564. PubMed ID: 33764851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex hormone-binding globulin is an independent predictor of biochemical recurrence after radical prostatectomy.
    Waldert M; Schatzl G; Swietek N; Rom M; Klatte T
    J Urol; 2012 Sep; 188(3):792-7. PubMed ID: 22818139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum prostate-specific antigen but not testosterone levels decrease in a randomized soy intervention among men.
    Maskarinec G; Morimoto Y; Hebshi S; Sharma S; Franke AA; Stanczyk FZ
    Eur J Clin Nutr; 2006 Dec; 60(12):1423-9. PubMed ID: 16775579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized clinical trial of brewed green and black tea in men with prostate cancer prior to prostatectomy.
    Henning SM; Wang P; Said JW; Huang M; Grogan T; Elashoff D; Carpenter CL; Heber D; Aronson WJ
    Prostate; 2015 Apr; 75(5):550-9. PubMed ID: 25545744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.